Invitation-Only Symposium
Relink Program
Connecting Patients Back to Care
Join CDAF and Relink program participants for an invitation-only symposium while attending The Liver Meeting® 2026 focused on practical strategies for identifying diagnosed individuals who are no longer engaged in care and successfully reconnecting them to treatment and support services.
Invitation Requests
Space is limited
Submitting the form does not guarantee attendance. Selected participants will receive confirmation and additional event details as invitations are finalized.
Learn What Works in Hepatitis B and C Patient Re-Engagement.
Thousands of people diagnosed with hepatitis B or hepatitis C remain outside the healthcare system despite the availability of effective care and treatment. The Relink grant program was created to help close this gap by identifying diagnosed but untreated individuals across diverse healthcare and community settings and supporting their return to care.
At this symposium, Relink grantees from across the United States will share real-world experiences, lessons learned, and actionable approaches from implementing patient re-engagement programs. Attendees will gain practical insights that can be adapted and applied in their own settings.
What You’ll Learn
How organizations are using patient registries and electronic health records, including Epic, to identify diagnosed but untreated individuals.
Practical approaches to cleaning and validating patient data, including removing records for individuals who have already received treatment or are deceased.
Common challenges and limitations associated with patient registries and how programs have addressed them.
Strategies for reconnecting diverse populations to care, including people who inject drugs, people experiencing homelessness, pregnant people, and immigrant communities.
Lessons learned from outreach approaches such as phone calls, text messaging, mailed letters, community engagement, and peer-led interventions.
Estimated staffing, resource, and cost considerations for implementing re-engagement programs.
Key factors that differentiate successful re-engagement from less effective approaches.
Meet the Presenters
Meet the Relink Grantees Sharing Real-World Strategies for Reconnecting Patients to Care
Presenters will showcase the challenges and successes encountered at each step of the Relink process—from patient identification and outreach to linkage-to-care outcomes.
San Francisco, CA
Presentation Topic
ReLink: Connecting Chronic Hepatitis B Patients with Liver Fibrosis Staging and Antiviral Treatment at a Community Health Center in Northern California
Florence, KY
Presentation Topic
Impact of Direct Mail Outreach for Hepatitis C Re-engagement in Northern Kentucky
Portland, OR
Presentation Topic
Community Partnerships Drive Targeted In-Person Outreach for Linking Individuals to HCV Care
Chicago, IL
Presentation Topic
Implementation of a multilevel intervention for re-linkage to care for diagnosed but untreated patients with hepatitis C infection (the REACH Program)
Chapel Hill, NC
Presentation Topic
Evaluating EHR Based Strategies to Identify Diagnosed but Untreated Hepatitis B and C Patients in North Carolina
Who Should Attend
This symposium is intended for individuals and organizations engaged in hepatitis B or hepatitis C care, public health, linkage-to-care efforts, elimination initiatives, research, or community-based outreach, including:
Healthcare providers
Public health professionals
Health system leaders
Care coordinators and patient navigators
Researchers and program implementers
Community-based organizations
Why Relink Matters
CDA Foundation has received an eight-million-dollar grant from Gilead Sciences to distribute to sub-grantees in 2023–2026.
The objective of the Relink program is to provide grants to find diagnosed-but-untreated HCV and HBV infected individuals and help them get linked to care. The program is treatment agnostic and Gilead will not have any influence on the design, implementation, and the RFP process including reviewing and evaluating of proposals. Diagnosed patients can go on any treatment recommended by their doctor.
Request an Invitation to the Relink Symposium
The Symposium is invitation-only and space is limited.
If you are interested in attending, please complete the interest form to be considered for an invitation.
Submitting the form does not guarantee attendance. Selected participants will receive confirmation and additional event details as invitations are finalized.
English 
Spanish 
French 
Chinese 
Russian 
Arabic